RESULTS:
The mean time as a donor was 25.9 6 15.2 hours and was not different between the groups. In the DI group 19% were transfused compared to 26% in the control group (p 5 0.3). The number of units transfused was less in the DI group (1 unit vs. 2 units per transfusion, p 5 0.03) and the pretransfusion hematocrit was lower in the DI group (23% vs. 27%, p 5 0.01). The variability in the latter two parameters was significantly lower in the DI group. The number of transplanted organs per donor was similar in both groups (3.24 [DI] vs. 3.03 [control], p 5 0.37).
CONCLUSION:
The DI provides a more standardization transfusion practice in organ donors and reduces blood use without compromising transplantable organs. C urrent trends in patient blood management favor the use of more standardized transfusion practices. Studies to determine and implement optimal transfusion thresholds have led to more conservative use of blood products in a variety of clinical settings, and a large body of literature now supports these standardized, more restrictive strategies. 1 The implementation of such standardized transfusion practices has resulted in a more cost-effective use of red blood cell (RBC) transfusion and, more importantly, has resulted in improved patient outcomes in a variety of clinical scenarios.
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Nonsurvivable donors are the major source of organs for transplant in most major transplant centers, including our own. This group of donors includes patients after the determination of brain death and patients in whom continued aggressive medical care is considered futile and such care is withdrawn allowing cardiac death before organ donation. Transfusion of blood products to maintain oxygen delivery and hemostasis is an important part of donor management before organ procurement. 4, 5 The ultimate goal in these donors is to preserve organ function so as to provide optimal organs for transplant. The care of this group of donors has historically been managed by physicians in an intensive care unit (ICU) setting, and in many transplant centers this represents a significant amount of physician manpower and care hours. Although general guidelines are available, the management of this group of donors varies widely at both the institutional and the individual provider level. [6] [7] [8] Restrictive transfusion strategies have been suggested in this patient group; however, data from implementation of such strategies are lacking in the literature. The Digital Intern (DI) is a proprietary, computerbased algorithm of care for the organ donor that was developed to standardize and automate care with the aim of reducing the direct physician time required to manage this group of ICU patients. The program interfaces directly with the electronic medical record and, based on set parameters, provides clinical recommendations to guide the care provided by ICU nursing and other ancillary staff. Once the authority is delegated, the program's numerous care algorithms interact with each other to make decisions on clinical care. One set of algorithms is designed to manage the transfusion of blood products before organ procurement. The algorithm for RBC transfusion is based on a restrictive RBC transfusion threshold of hematocrit (Hct) level of less than 24%. The DI will order transfusion of RBCs based on the Hct and donor weight, employing a mathematical formula to calculate the number of units (or volume) of RBCs to transfuse to the patient. Historically, the managing physician empirically determined when and how much blood to transfuse before organ procurement.
A comparison of transfusion management of organ donors by the DI and ICU physicians has not been reported. We hypothesized that organ donor management by the DI would improve standardization and reduce blood utilization without compromising the quality of harvested organs. To explore this hypothesis we compared the transfusion histories and organ procurement outcomes of 100 consecutive donors cared for since the implementation of the DI system to a historical group of 90 physician-managed, control donors.
MATERIALS AND METHODS

Donor patient population selection and medical record review
This retrospective review of nonsurvivable organ donors was reviewed and approved by the University of Wisconsin Health Sciences Institutional Review Board. Organ donor subjects were identified from the University of Wisconsin Donor Index database. Between January 1, 2012, and December 31, 2015, a total of 104 donor subjects had blood product management after implementation of the DI system. Ninety-one consecutive donors were identified between January 1, 2009, and December 31, 2011, and were used as a physician-managed, control group. Electronic medical records were reviewed for date of admission, date and time of death (clinical examination documenting brain death, nuclear medicine scan showing absence of cerebral blood flow, or documentation of the futility of clinical care and transition to organ donation status), and the date and time of organ procurement. The predonor status period was defined as admission until documented brain death or futility of care and the donor period as the time from brain death or futility of care until organ procurement, in hours. Cases were categorized based on the mechanism of death (trauma [violent or accidental] vs. medical [including intracranial vascular accidents]) and the donor type as brain dead donor or donation after cardiac death. The date and time of orders placed for RBC transfusion were recorded, and each RBC unit was assigned to the predonor or donor time period for analysis. Blood products that were ordered but not transfused, as well as transfusions given during the procurement procedure (not assigned by the DI), were not included in the analysis for either group. All Hct values in the donor period were recorded. The total number of Hct values as well as the mean and median were calculated for each donor. Hct values immediately preceding transfusion orders were considered the pretransfusion Hct for each transfusion given during the donor period. The number of organs procured per donor was obtained from the University of Wisconsin Donor Index. The organs were categorized as transplanted, used for transplant research, or as discarded if they were of poor quality and not used for either indication.
Among the DI cases, there was a variable time interval between time of death and initiation of the DI protocol in the medical record. The mean delay was 2.8 hours and affected the assignment of blood products in only one case. We therefore applied the predonor and donor status time determinations consistently across both groups in an intent-to-treat model, without regard for the time lag between determination of death and implementation of the DI.
Statistical analysis
Comparison of transfusion rates between groups was determined by contingency table analysis using the Fisher's exact test. The number of units of RBCs transfused, pretransfusion laboratory values, and the number of transplantable organs per donor were reported as the median with interquartile range and/or the mean with standard error of the mean. These parameters were then compared by the Mann-Whitney U test (Wilcoxon rank sum test) and/or the t test. Differences in the variability as measured by the coefficient of variation (CV) were compared between groups with the two-tailed F test. t test and chi-square analysis were used to compare all other continuous and categorical clinical variables, respectively. Statistical analyses were preformed using computer software (GraphPad Prism 5, GraphPad, Inc.) and significance was set at a p value of less than 0.05 for all analyses.
RESULTS
A total of 190 donors were cared for at the University of Wisconsin during the study period and had complete records for review, 90 in the historical control group and 100 in the DI group. Table 1 describes the general characteristics and transfusion histories of the two groups. Both the mechanism of death (trauma vs. medical) and the donor type (brain dead donor vs. donation after cardiac death) were equally distributed between the control and DI groups. The mean time as a donor before procurement was 25.9 6 15.2 hours and was not different between the groups (24.7 hr control and 27.1 hr DI, p 5 0.2).
The mean Hct during the donor time period was 32 6 7% for the historic control group and 31 6 6% for the DI group (p 5 0.8). The mean number of Hct values obtained during the donor period was not different between the groups: 4.2 6 2 and 4.5 6 3 Hct values for the control and DI group, respectively (p 5 0.5)
Nineteen of the 100 donors (19%) in the DI group were transfused during the donor period compared to 26% (23 of 90) in the control group. Although the rate of transfusion was 7% lower in the DI group this difference in transfusion rate is not significant (p 5 0.30, Fig. 1 ). In the DI group, five donors were transfused at two separate times during the donor period. In the control group, four donors were transfused twice and one donor was transfused three separate times.
In the DI group, 19 donors received a total of 24 transfusions with a mean of 1. (Fig.  4A, p 5 0,003) and also show that the number of subjects transfused beyond the DI's threshold of 24 in the control group approaches 50% (Fig. 4B, p 5 0.0002) . In Fig. 5 , the number of units transfused for any given pretransfusion Hct shows greater variability in the control group (Fig.  5A) , CV 28% to 65%, than in the DI group (Fig. 5B) , CV 28% to 35%, over the same range of Hct values. Table 2 shows that patients who presented as victims of trauma were more likely to be transfused than patients with medical diagnosis before becoming an organ donor in both the control and the DI groups (Tables 2A and 2B) . After becoming an organ donor, however, there remains a trend toward more transfusions for trauma cases in the control group only (Table 2C ). In the DI group the rate of donor transfusion is no different between the trauma and medical cases (Table 2D) .
The number of organs procured per donor was significantly higher in the DI group (4.07 vs. 3.54 organs per donor, p 5 0.019). Although the number of organs transplanted per donor was higher in the DI group, 3.24 (DI) versus 3.03 (control) organs per donor, this did not achieve significance. There was no difference between the groups for the number of organs that were discarded as nontransplantable. In the DI groups there was also a significant increase in the number of organs allocated to transplant research (Table 3 ). The number of transplanted organs was higher for the brain dead donors compared to donation after cardiac death donors in both the control and the DI groups (control 3.43 vs. 2.6 organs [p 5 0.005] and DI 3.92 vs. 2.50 organs [p < 0.001], brain dead vs. donation after cardiac death); however, as seen in Table 1 the donor types are equally distributed in each group. Similarly, the number of organs transplanted did not differ between donors who presented as victims of trauma compared to those with medical diagnosis for either the control or the DI groups (control 2.94 vs. 3.16 organs 
DISCUSSION
Current health care recommendations emphasize standardized practices for the use of blood products. Institution-wide, standardized transfusion practices can reduce morbidity associated with transfusion without compromising clinical outcomes. [1] [2] [3] Many transfusion protocols have adopted more restrictive use of RBC transfusion with lower transfusion thresholds. In many studies, morbidity, defined by the incidence of end-organ dysfunction, has been shown to be more prevalent in patients who were liberally transfused compared to those managed with more restrictive practices. One possible exception is in the care of patients with ischemic cardiac disease, in which more liberal use of RBC transfusion may be beneficial. 9, 10 Nonsurvivable organ donors include patients who meet the criteria for brain death as well as patients on life support where continued intensive and supportive care is considered to be futile. This group of donors is an increasing source of organs for transplantation. Clinical care of the organ donor before procurement is complex due to the multiple physiologic changes occurring in critically ill patients and after cerebral death. These changes include dysfunctional temperature regulation, altered vascular tone with hemodynamic instability (usually episodic hypotension), endocrine dysfunction, and at times, coagulopathy. Care of these donors before organ procurement may include the transfusion of blood products to maintain tissue oxygen delivery and to support hemostasis. Compared to general clinical practice, the optimal use of The goal of optimal care in this setting is to preserve functioning organs for transplant. Guidelines and opinions on the medical management of this group of organ donors have been published; however, practice is quite variable from institution to institution as well as from physician to physician. Transfusion practice in organ donors is equally variable, and published guidelines can be found to support any of the different opinions and approaches to care. Only one single-institution retrospective review from Vanderbilt University has been published describing transfusion practices in organ donors. The authors report a RBC transfusion rate of 69% in a presumed physician-managed setting, with no clearly defined transfusion threshold.
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Some sources recommend transfusion to maintain hemoglobin (Hb) concentrations greater than 10 g/dL until the time of organ procurement for all donors. 6 Others recommend different transfusion thresholds based on the clinical stability of the donor. For example, the Brazilian Associations of Intensive Medicine and Organ Transplantation recommend transfusing all donors with Hb level of 7 g/dL, not transfusing any donor with Hb level of more than 10 g/dL, and only transfusing donors with Hb concentrations between 7 and 10g/dL if they are not hemodynamically stable. 7 The DI is a proprietary computer-based algorithm designed to provide predictable, physiologically adaptive care to nonsurvivable organ donors and to minimize physician time required to care for this group of patients. The program interfaces directly with the electronic medical record and, based on set parameters, provides patient care recommendations to guide the care provided by ICU nursing and other ancillary staff.
The program uses a Hct threshold of less than 24% to determine the need for RBC transfusion, then uses mathematical algorithms, including the Hct and the donor weight, to calculate the number of units (or volume) of RBCs to transfuse. The DI then enters into the electronic medical record an order for RBC units, an order to transfuse those units, and orders for follow-up laboratory testing.
As shown in this study, delegating transfusion decision-making authority to the DI eliminated the need for direct physician input and led to a nonsignificant reduction in the transfusion rate from 26% to 19%. Although the transfusion rate only decreased modestly, the number of units per transfusion was significantly reduced from a median of 2 units per donor in the control group to 1 unit per donor in the DI-managed patients. There was not a significant difference in the number of donors transfused more than once in the two groups, and there is a trend toward fewer total RBC units transfused per donor in the DI group, from 2.5 units/donor (58 units) in the control group to 1.8 units/donor (34 units) in the DI-managed group. Taken together, the data indicate that use of the DI reduces RBC transfusion in the nonsurvivable organ donor population.
This study demonstrates improved standardization of transfusion practice with implementation of the DI. There is significantly less variability in the number of units transfused and in the indication for the transfusion, based on the pretransfusion Hct. The CV for the pretransfusion Hct was three times greater (22% vs. 7%) in the physicianmanaged group compared to the DI. Similarly, the number of units transfused was more consistent in the DI group. The reduced variability in transfusion practice is the result of the use of a standard algorithm to determine which donors to transfuse and how much blood should be given based on the pretransfusion Hct. In this study population, if the DI algorithm were to be applied to the control group 48% of the transfusions given would not have been prescribed.
As might be expected patients who present to the hospital as a victim of a trauma are transfused more often than those who present with medical diagnosis in the predonor period. In the donor period we see this trend continuing in the physician-managed patients only again underscoring the standardization of transfusion practice provided via the DI. Based on the results observed in this study, the DI system has the potential to significantly reduce the use of RBC transfusions in organ donors.
The ultimate outcome in this population is the availability of optimally functioning organs for transplant. The long-term function of transplanted organs is beyond the scope of this study; however, the number of organs transplanted per donor was not negatively impacted by the implementation of the DI. It remains to be determined if donors managed via the DI system will result in improved long-term organ function. Finally, we anticipate a significant savings in health care costs from reduced physician ICU billable hours of work to care for this group of donors. In conclusion, the implementation of the DI system has significantly improved the standardization of RBC transfusion practice in the nonsurvivable organ donor population and will likely result in lower utilization of RBCs without compromising the quality of procured transplantable organs.
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